Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Dipna Pharmachem Limited, is a listed public company incorporated on 19 July, 2011. It is classified as a public limited company and is located in , Gujarat. It's authorized share capital is INR 25.50 cr and the total paid-up capital is INR 24.05 cr.
Dipna Pharmachem Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2024. It's EBITDA has increased by 46.32% over the previous year. At the same time, it's book networth has increased by 54.03%.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Dipna Keyur Shah
Shareholder
|
02507462 | 14 years |
| Managing Director | Keyur Dipakkumar Shah
Shareholder
|
03167258 | 4 years |
| Director | Nandish Shaileshbhai Jani | 09565657 | 3 years |
| Director | Parin Shirishkumar Bhavsar | 09134264 | 1 years |
| Director | Nirav M Soni | 08317653 | 1 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
AU SMALL FINANCE BANK LIMITED
No. of Loans: 2
Total Amount : 9.2 cr
GROWTH SOURCE FINANCIAL TECHNOLOGIES PRIVATE LIMITED
No. of Loans: 1
Total Amount : 2.1 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| DHARA PHARMACHEM PRIVATE LIMITED |
Active
|
18.7 L | 2 | Gujarat |
| DIPAN PHARMACHEM PRIVATE LIMITED |
Active
|
1.0 L | 2 | Gujarat |
| AURIC IMPEX PRIVATE LIMITED |
Active
|
1.0 L | 1 | Gujarat |
| BLEACH ENERGY LLP |
Under process of striking off
|
1.0 L | 1 | Gujarat |
| RISE PHARMA CHEM LLP |
Active
|
1.0 L | 2 | Gujarat |
| MADHUSUDAN PETROCHEM PRIVATE LIMITED |
Active
|
1.0 L | 1 | Gujarat |
| YARN SYNDICATE LTD |
Active
|
3.8 Cr | 1 | West Bengal |
| MAGENTA LIFECARE LIMITED |
Active
|
6.9 Cr | 1 | Gujarat |
Read more
The incorporation date of DIPNA PHARMACHEM LIMITED is 19 July, 2011
The authorized share capital of DIPNA PHARMACHEM LIMITED is INR ₹ 25.5 Cr.
The paid-up capital of DIPNA PHARMACHEM LIMITED is INR ₹ 24.0 Cr.
The registered address of DIPNA PHARMACHEM LIMITED is A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055 - 380055
The CIN number of DIPNA PHARMACHEM LIMITED is L24100GJ2011PLC066400.